Cel-Sci
CVM
#10616
Rank
$20.27 M
Marketcap
$1.16
Share price
-4.92%
Change (1 day)
-87.72%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $10.83 Million USD

According to Cel-Sci 's latest financial reports the company's total liabilities are $10.83 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30$12.19 M-13.64%
2024-09-30$14.12 M-18.42%
2023-09-30$17.31 M-5.7%
2022-09-30$18.36 M-5.04%
2021-09-30$19.33 M-7.08%
2020-09-30$20.8 M-7.47%
2019-09-30$22.48 M-23.99%
2018-09-30$29.58 M12.66%
2017-09-30$26.26 M2.72%
2016-09-30$25.56 M-23.26%
2015-09-30$33.31 M279.15%
2014-09-30$8.78 M112.33%
2013-09-30$4.13 M-54.22%
2012-09-30$9.04 M-5.31%
2011-09-30$9.54 M-4.06%
2010-09-30$9.95 M-73.24%
2009-09-30$37.18 M866.49%
2008-09-30$3.84 M-36.52%
2007-09-30$6.06 M-42.74%
2006-09-30$10.58 M971.99%
2005-09-30$0.98 M-29.05%
2004-09-30$1.39 M-17.67%
2003-09-30$1.69 M-37.61%
2002-09-30$2.7 M433.57%
2001-09-30$0.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 1,104,971.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.31 B 769,004.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.22 B 1,942.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
$16.97 M 56.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$31.80 B 293,532.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
$1.01 B 9,305.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.79 B 7,260.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$3.68 M-65.99%๐Ÿ‡บ๐Ÿ‡ธ USA